Be part of the knowledge.™

Neurology and Neurosurgery

333

LikeLikedUnlike

46-60 of 64

Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
MinuteCE®
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
- Vera Bril, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CE
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
- Ahmed Z. Obeidat, MD, PhD
  Peer
0.25 credits
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CE
The Safety of Sodium Oxybate in Treating Narcolepsy
- Clete A. Kushida, MD, PhD
  Peer
- Sally Ibrahim, MD, FAAP
  Peer
0.50 credits
MinuteCE®
Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 credits 10 episodes
Decoding CIDP: Exploring Common and Atypical Variants
MinuteCE®
Decoding CIDP: Exploring Common and Atypical Variants
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
MinuteCE®
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
advertisement
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
MinuteCE®
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
MinuteCE®
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Implementing CIDP Clinical Guidelines: Optimizing Therapy
MinuteCE®
Implementing CIDP Clinical Guidelines: Optimizing Therapy
- Nicholas J. Silvestri, MD
  Peer
- Jeffrey Allen, MD
  Peer
1.00 program credits
Novel Mechanisms of Action: FcRn Inhibitors
MinuteCE®
Novel Mechanisms of Action: FcRn Inhibitors
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
advertisement
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
- Nicholas J. Silvestri, MD
  Peer
- Jeffrey Allen, MD
  Peer
1.00 program credits
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
MinuteCE®
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CE
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
- Omer Abdul Hamid, MD
  Peer
- Nancy Kuntz, MD
  Peer
- Migvis Monduy, MD
  Peer
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended